Abstract
Purpose
The purpose of the study was to evaluate the post-contrast appearance of local tumor progression (LTP) following renal ablation to better understand patterns of tumor recurrence and to optimize follow-up imaging protocols.
Methods
From 2002 to 2015, 913 patients underwent 988 renal ablation procedures for treatment of 1064 tumors. LTP was identified in 24 (2.6%) patients during median imaging follow-up of 30 months (range 0–139). One patient with LTP was followed with non-contrast MRI only and was excluded from evaluation. Three body radiologists reviewed the contrast-enhanced CT and/or MRI follow-up imaging in the remaining 23 patients to determine the timing and imaging appearance of the recurrent tumor.
Results
Local tumor progression was identified on contrast-enhanced CT or MRI at median 11 months (range 1 and 68) after renal ablation. Corticomedullary phase imaging was performed in 16/23 (70%) patients. LTP was identified on the corticomedullary phase in all cases, and was most conspicuous on the corticomedullary phase compared to any other phase of imaging in 15/16 (94%) patients. No cases of LTP were best visualized on non-contrast or excretory phase images.
Conclusions
Delayed recurrence following renal ablation is possible; therefore, extended follow-up is indicated in ablation patients. Almost all cases of LTP were best visualized on the corticomedullary phase of imaging, which should be included in any post-ablation imaging protocol. Excretory phase images were not required to diagnose LTP in any case and could be excluded from routine post-ablation follow-up.
Similar content being viewed by others
References
Hui GC, Tuncali K, Tatli S, et al. (2008) Comparison of percutaneous and surgical approaches to renal tumor ablation: metaanalysis of effectiveness and complication rates. J Vasc Interv Radiol 19(9):1311–1320
Thompson RH, Atwell T, Schmit G, et al. (2015) Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 67(2):252–259
Ahmed M, Solbiati L, Brace CL, et al. (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update. Radiology 273(1):241–260
Casalino DD, Remer EM, Bishoff JT, et al. (2014) ACR appropriateness criteria post-treatment follow-up of renal cell carcinoma. J Am Coll Radiol 11(5):443–449
Donat SM, Diaz M, Bishoff JT, et al. (2013) Follow-up for clinically localized renal neoplasms: AUA guideline. J Urol 190(2):407–416
Jain Y, Liew S, Taylor MB, et al. (2011) Is dual-phase abdominal CT necessary for the optimal detection of metastases from renal cell carcinoma? Clin Radiol 66(11):1055–1059
Wile GE, Leyendecker JR, Krehbiel KA, et al. (2007) CT and MR imaging after imaging-guided thermal ablation of renal neoplasms. Radiographics 27(2):325–339 (discussion 339–340)
Arnold DC 2nd, Schroeder G, Smith JC, et al. (2013) Comparing radiation exposure between ablative therapies for small renal masses. J Endourol 27(12):1435–1439
McEachen JC, Leng S, Atwell TD, et al. (2016) Percutaneous renal tumor ablation: radiation exposure during cryoablation and radiofrequency ablation. Cardiovasc Intervent Radiol 39(2):233–238
Eisenberg JD, Gervais DA, Singh S, et al. (2015) Radiation exposure from CT-guided ablation of renal masses: effects on life expectancy. Am J Roentgenol 204(2):335–342
Atwell TD, Schmit GD, Boorjian SA, et al. (2013) Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. Am J Roentgenol 200(2):461–466
Gervais DA, McGovern FJ, Arellano RS, et al. (2005) Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. Am J Roentgenol 185(1):64–71
Derweesh IH, Malcolm JB, Diblasio CJ, et al. (2008) Single center comparison of laparoscopic cryoablation and CT-guided percutaneous cryoablation for renal tumors. J Endourol 22(11):2461–2467
Vikram R, Ng CS, Tamboli P, et al. (2009) Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease. Radiographics 29(3):741–754 (discussion 755–757)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Funding
This study received no extramural funding.
Ethical approval
This study was approved by our institutional review board and was compliant with the Health Insurance Portability and Accountability act. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.
Rights and permissions
About this article
Cite this article
Eiken, P.W., Atwell, T.D., Kurup, A.N. et al. Imaging following renal ablation: what can we learn from recurrent tumors?. Abdom Radiol 43, 2750–2755 (2018). https://doi.org/10.1007/s00261-018-1541-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-018-1541-0